World AIDS Vaccine Day 2024: Prophylactic vaccines in phase II development hold potential to reduce epidemic burden
According to key opinion leaders (KOLs) interviewed by GlobalData, the prevalence of HIV will reduce in the future, partly due to better treatment options, the availability of PrEP, and the development of prophylactic vaccines.